Rodent Inhalation Testing
Our state-of-the-art facility provides a range of testing solutions, including in-vitro exposure, OECD toxicity studies, pharmaceutical efficacy, and inhalation dose models, ensuring that your research meets the highest standards of accuracy, safety, and regulatory compliance.
Pharmaceutical: We conduct detailed assessments of the therapeutic effects of pharmaceutical aerosols, studying their mechanisms of action, bioavailability, and distribution within rodent models. Our toxicological testing evaluates the potential side effects and safety profile of aerosolized drugs, ensuring they meet stringent safety standards.
OECD Toxicity: Our rodent studies are meticulously designed to align with OECD toxicity testing guidelines, ensuring that your aerosol products meet the rigorous international standards for inhalation safety. We specialize in assessing the toxicological effects of aerosols on rodent models, providing crucial data on potential health risks associated with inhalation exposure to various substances.
Inhalation Dose Models: Our inhalation dose models are meticulously designed to accurately measure the dosage received by rodents during inhalation exposure. This precision is crucial for studies in pharmacokinetics, toxicology, and drug efficacy. These protocols are aligned with industry standards, ensuring that our testing services provide reliable and actionable results.
In-Vitro Exposure: In-Vitro testing includes assessments of particle size distribution, aerosol composition, and delivery efficiency. Catering to devices like medical inhalers, nebulizers, dental drills, and aerosolized disinfectant systems, we tailor our testing protocols to address the unique challenges presented by each type of aerosol-producing equipment.
In-Vitro Inhalation Exposures
Our specialized in-vitro inhalation test services provide crucial insights for the development and evaluation of inhalation products. In an industry where precision and safety are paramount, our advanced in-vitro testing methods offer an ethical, efficient, and effective alternative to traditional in-vivo testing. Our services are essential for pharmaceutical companies, research institutions, and healthcare providers focused on respiratory health and inhalation therapies.
Systems: Our in-vitro anatomical model testing services offer unparalleled insight into respiratory drug delivery and aerosol distribution. Our state-of-the-art testing methodologies, including cascade impactor testing, ventilated human models, nasal models, and surface deposition analysis, provide critical data for the development and evaluation of respiratory therapies and products.
Pharmaceuticals: We offer specialized in-vitro pharmaceutical testing services are dedicated to enhancing the efficacy and safety of respiratory drugs. Our state-of-the-art in-vitro testing methods provide comprehensive insights into dose deposition, alveolar delivery, and total dosing of respiratory medications, ensuring optimal therapeutic outcomes.
Consumer Products: ARE Labs is your expert resource for inhalation exposure testing of consumer products. Understanding the potential health impacts of inhalation is crucial in today's market, where consumers are more aware and concerned about product safety. Our advanced testing services provide essential insights into the inhalation risks associated with various consumer products, using simulated use scenarios, estimated dosing analysis, and sophisticated respiratory models.
Breathing Simulation: Our cutting-edge in-vitro inhalation testing services utilize a custom human ventilated model to simulate real-world human breathing conditions. This advanced approach is pivotal for pharmaceutical companies, chemical manufacturers, and healthcare researchers who are committed to understanding and improving respiratory health and treatment efficacy.
Commitment to Excellence
At ARE Labs, our dedication to supporting pharmaceutical innovation is matched by our commitment to meeting stringent clinical and regulatory standards. Our inhalation test services are integral to the development process, ensuring products not only achieve but exceed the necessary benchmarks for therapeutic efficacy and patient safety.